Artialis: Passion for Healthy Aging
Artialis, a leading Contract Research Development Organization (CRDO), specializes in musculoskeletal health. Offering a comprehensive range of services from preclinical research to post-marketing surveillance.
Founded in 2010, Artialis emerged from the University of Liege’s Bone and Cartilage Research Unit. With a strong foundation in scientific research, Artialis has grown into a trusted partner for pharmaceutical and biotech companies worldwide.
Over the past 14 years, Artialis has successfully completed 142 R&D projects, leveraging the combined expertise of its team, which boasts over 75 years of experience in the industry. This wealth of knowledge allows Artialis to provide tailored solutions and navigate the complexities of product development.
Driven by a commitment to client satisfaction, the company has achieved a remarkable 90% satisfaction rate.
Lear more: www.artialis.com
A LEADING POSITION AND
AN INTERNATIONAL DEPLOYMENT
64 +
countries
involved
20 000 +
investigational
Centres
3 million +
patients
in database
50 000 +
users
worlwide
LATEST NEWSOUR NEWS >
February 27, 2025
18 – 20 march – Basel, Switzerland Register Now DIA Europe 2025 will focus on sustainability, innovation and collaboration – three key pillars for shaping the future of healthcare. From the environmental impact of pharmaceuticals and of the drug development lifecycle to sustainable partnerships and sustainable healthcare systems, DIA Europe 2025 will be the prime opportunity to discuss how collaboration and […]
February 27, 2025
Med City News From the executive boardrooms of pharma companies to academic research centers, one fact is becoming unmistakably clear: making radiopharmaceuticals is an inherently complex, high-stakes endeavor, and the industry is racing to manage the risks of these perishable therapies before the clock runs out. Somewhere in a laboratory, tucked away in its vessel, […]
February 27, 2025
Applied Clinical Trials Artificial intelligence (AI) is the biggest transformation in life sciences in the last 25 years—an advancement akin to mapping the human genome, with potential for a much higher rate of scientific breakthroughs over the next decade. But there’s still a lot to consider when applying AI to clinical development and product commercialization, […]